Hungary

BMI View: Hungary-based Egis has posted weak financial figures for its 2009/10 business year. The company's financial results are based on revenues from October 1 2009 to September... 2010-11-11

BMI View: Despite stronger growth potential in emerging pharmaceutical markets, drugmakers based in developing countries are set to increase their presence in developed states. In the... 2010-11-04

BMI View: The attractiveness of Central and Eastern Europe (CEE) to multinational pharmaceutical companies has declined. The region scored 51.5 out of 100 in BMI's Pharmaceutical &... 2010-10-27

Developed state underperformance remains a recurring theme within our Industry analysis. We remain concerned about US labour market weakness and its impact, particularly on consumer... 2010-09-28

Gedeon Richter, the leading pharmaceutical producer in Hungary, has released its H110 financial results. Weakness in the local currency meant that exports boosted the bottom line. In... 2010-08-05

BMI is maintaining its forecast for pharmaceutical expenditure in Hungary, despite a tumultuous weekend that saw the IMF and EU walk away from negotiations with the Hungarian government.

Gedeon Richter has entered a collaboration agreement with Indian firm Astron Research to develop and expand the Hungarian firm's portfolio of generic drugs. Richter claims the deal... 2010-03-26

BMI has introduced greater clarity to its core views for the Pharmaceuticals & Healthcare. Short-term core views concern the period through to the end of the 2011-2013 patent cliff,... 2010-03-15

The presence of countries from BMI's Emerging Europe Region in the Pharmaceutical Research and Manufacturers of America (PhRMA)'s Special 301 Submission 2010 remains largely equivalent... 2010-03-11

Hungarian generics firm Egis has acquired distribution rights for biosimilar products from South Korean biotechnology company Celltrion across markets in Central and Eastern Europe... 2010-02-12